Biodesix Stock Pattern Recognition Two Crows
| BDSX Stock | USD 17.88 -1.27 -6.63% |
| Symbol |
Recognition |
Biodesix Technical Analysis Modules
Most technical analysis of Biodesix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biodesix from various momentum indicators to cycle indicators. When you analyze Biodesix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Methodology
Unless otherwise specified, financial data for Biodesix is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Biodesix (USA Stocks:BDSX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Biodesix is covered by 5 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include RBC Capital Markets, Barclays, HSBC Global Research, Wells Fargo Securities, Bank of America Securities, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardTrending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Momentum Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Advertising Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Cash Cows Invested few shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Disruptive Technologies Invested few shares |
More Resources for Biodesix Stock Analysis
Reviewing Biodesix commonly begins with financial statements and performance trends. Ratios and trend metrics help frame Biodesix's operating context. Outlined below are key reports that provide context for Biodesix Stock: Earnings Share -4.67 | Revenue Per Share | Quarterly Revenue Growth 0.408 | Return On Assets | Return On Equity |